UNITED-GUARDIAN, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 8.42 USD | +3.44% |
|
+7.12% | +16.94% |
| Mar. 22 | United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
| Mar. 22 | United-Guardian, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
| Sales 2022 | 12.7M | Sales 2023 | 10.89M | Capitalization | 33.08M |
|---|---|---|---|---|---|
| Net income 2022 | 2M | Net income 2023 | 2M | EV / Sales 2022 | 3.27 x |
| Net cash position 2022 | 6.48M | Net cash position 2023 | 9.09M | EV / Sales 2023 | 2.2 x |
| P/E ratio 2022 |
18.7
x | P/E ratio 2023 |
12.8
x | Employees | 24 |
| Yield 2022 |
6.51% | Yield 2023 |
4.86% | Free-Float | 63.61% |
More Fundamentals
* Assessed data
More news
Latest transcript on United-Guardian, Inc.
| 1 day | +3.44% | ||
| 1 week | +7.12% | ||
| Current month | +10.07% | ||
| 1 month | +4.73% | ||
| 3 months | +14.25% | ||
| 6 months | +36.02% | ||
| Current year | +16.94% |
1 week
7.79
8.42
1 month
7.358.42
Current year
7.029.37
1 year
5.7910.23
3 years
5.7926.09
5 years
5.7926.09
10 years
5.7935.25
| Managers | Title | Age | Since |
|---|---|---|---|
Donna Vigilante
PSD | President | 44 | - |
Andrea J. Young
DFI | Director of Finance/CFO | 55 | 16-08-31 |
| Chairman | 72 | 83-12-31 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 78 | 01-12-31 | |
| Director/Board Member | 82 | 96-12-31 | |
| Director/Board Member | 66 | 93-12-31 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-24 | 8.42 | +3.44% | 8,869 |
| 24-04-23 | 8.14 | +0.12% | 5,590 |
| 24-04-22 | 8.13 | +1.50% | 5,819 |
| 24-04-19 | 8.01 | +1.91% | 4,929 |
| 24-04-18 | 7.86 | 0.00% | 3,701 |
Delayed Quote Nasdaq, April 24, 2024 at 04:00 pm EDT
More quotes
United-Guardian, Inc. is engaged in manufacturing and marketing cosmetic ingredients, pharmaceutical products, medical lubricants and sexual wellness ingredients. Cosmetic ingredients include a line of multifunctional hydrogel formulations designed to offer sensory enhancement, lubrication, texture and moisturization to personal care products. Its cosmetic ingredients include Lubrajel Natural, Lubrajel Marine, Lubrajel Oil Natural and Lubrajel Terra. Medical lubricants include a line of hydrogel formulations designed to offer sensory enhancement and lubrication to medical products. Pharmaceutical products include an FDA approved prescription drug that is used primarily to prevent and to dissolve calcifications in urethral catheters, as well as a chlorine-based topical antimicrobial. Sexual wellness ingredients include a line of hydrogel formulations designed to offer sensory enhancement, lubrication and moisturization to sexual wellness applications.
Sector
Pharmaceuticals
Calendar
2024-05-08
- Q1 2024 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| +16.94% | 38.68M | |
| +25.61% | 660B | |
| +23.33% | 562B | |
| -5.24% | 358B | |
| +16.49% | 322B | |
| +8.28% | 297B | |
| +12.51% | 219B | |
| -9.86% | 196B | |
| +6.83% | 199B | |
| -8.75% | 149B |
- Stock Market
- Equities
- UG Stock
